We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PLSE

Price
17.93
Stock movement up
+1.00 (5.91%)
Company name
Pulse Biosciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
1.10B
Ent value
1.04B
Price/Sales
633.90
Price/Book
13.94
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-16.76%
1 year return
50.04%
3 year return
108.09%
5 year return
12.39%
10 year return
-
Last updated: 2025-05-29

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

PLSE does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales633.90
Price to Book13.94
EV to Sales596.48

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count61.52M
EPS (TTM)-0.76
FCF per share (TTM)-0.56

Income statement

Loading...
Income statement data
Revenue (TTM)1.74M
Gross profit (TTM)604.00K
Operating income (TTM)-48.53M
Net income (TTM)-46.13M
EPS (TTM)-0.76
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)34.71%
Operating margin (TTM)-2789.02%
Profit margin (TTM)-2651.32%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash79.03M
Net receivables0.00
Total current assets80.41M
Goodwill2.79M
Intangible assets1.39M
Property, plant and equipment11.68M
Total assets93.05M
Accounts payable1.73M
Short/Current long term debt8.37M
Total current liabilities6.74M
Total liabilities13.91M
Shareholder's equity79.13M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-33.98M
Capital expenditures (TTM)115.00K
Free cash flow (TTM)-34.09M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-58.30%
Return on Assets-49.58%
Return on Invested Capital-56.59%
Cash Return on Invested Capital-41.82%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open16.95
Daily high18.18
Daily low16.75
Daily Volume159K
All-time high44.27
1y analyst estimate5.00
Beta1.75
EPS (TTM)-0.76
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
PLSES&P500
Current price drop from All-time high-59.50%-4.11%
Highest price drop-97.22%-56.47%
Date of highest drop30 Aug 20229 Mar 2009
Avg drop from high-59.81%-11.06%
Avg time to new high40 days12 days
Max time to new high1081 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
PLSE (Pulse Biosciences Inc) company logo
Marketcap
1.10B
Marketcap category
Small-cap
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Employees
56
Investor relations
-
SEC filings
CEO
Darrin R. Uecker
Country
USA
City
Hayward
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...